Markets

Sector Update: Healthcare

Healthcare shares were mixed in pre-market trade on Monday.

In healthcare stocks news, Allergan ( AGN ) said it still considers Valeant Pharmaceutical International's (VRX, VRX.TO) business model to be unsustainable and that the $72-per share and 0.83 Valeant stock offer creates "significant risks and uncertainties for Allergan shareholders."

Allergan said Valeant's business model relies on "serial acquisitions and cost reductions, as opposed to top-line revenue growth and operational excellence."

And, Gilead Sciences, Inc. ( GILD ) shares were up slightly after it reported topline results from a Phase 3 clinical trial in Japan evaluating the investigational once-daily fixed-dose combination for the treatment of genotype 1 chronic hepatitis C virus infection.

GILD trades in a 52-week range of $46.70 to $84.88.

Also, Response Genetics ( RGDX ) which is focused on the development and sale of molecular diagnostic tests that help guide cancer therapy selection, announced new testing capabilities to advance cancer immunotherapy clinical development.

RGDX was steady pre-market, having closed up 2.8% at $0.91.

Finally, Cephid ( CPHD ) said early Monday it has released Xpert Carba-R, an on-demand molecular test for rapid and accurate detection of carbapenemase-producing Gram-negative bacteria, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

GILD

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More